Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise
Clinical trial NCT04472494 · TERMINATED
Trial details
- NCT number
- NCT04472494
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-14
- Primary completion
- 2021-08-12
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.